nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—CES1—obesity	0.443	0.658	CbGaD
Dabigatran etexilate—F2—obesity	0.23	0.342	CbGaD
Dabigatran etexilate—UGT2B15—gall bladder—obesity	0.00456	0.0747	CbGeAlD
Dabigatran etexilate—UGT2B15—islet of Langerhans—obesity	0.00299	0.049	CbGeAlD
Dabigatran etexilate—NQO2—hindbrain—obesity	0.00252	0.0413	CbGeAlD
Dabigatran etexilate—F2—gall bladder—obesity	0.0025	0.0409	CbGeAlD
Dabigatran etexilate—CES1—gall bladder—obesity	0.00229	0.0376	CbGeAlD
Dabigatran etexilate—CES2—islet of Langerhans—obesity	0.00182	0.0299	CbGeAlD
Dabigatran etexilate—UGT2B15—digestive system—obesity	0.00179	0.0294	CbGeAlD
Dabigatran etexilate—CES2—respiratory system—obesity	0.00172	0.0282	CbGeAlD
Dabigatran etexilate—NQO2—islet of Langerhans—obesity	0.00163	0.0267	CbGeAlD
Dabigatran etexilate—F2—respiratory system—obesity	0.00155	0.0253	CbGeAlD
Dabigatran etexilate—UGT2B15—endocrine gland—obesity	0.00148	0.0243	CbGeAlD
Dabigatran etexilate—CES2—adrenal cortex—obesity	0.00145	0.0237	CbGeAlD
Dabigatran etexilate—CES1—respiratory system—obesity	0.00142	0.0233	CbGeAlD
Dabigatran etexilate—UGT1A9—digestive system—obesity	0.00136	0.0223	CbGeAlD
Dabigatran etexilate—UGT2B15—liver—obesity	0.00134	0.0219	CbGeAlD
Dabigatran etexilate—CES2—cardiovascular system—obesity	0.00132	0.0216	CbGeAlD
Dabigatran etexilate—NQO2—adrenal cortex—obesity	0.00129	0.0212	CbGeAlD
Dabigatran etexilate—F2—cardiovascular system—obesity	0.00118	0.0194	CbGeAlD
Dabigatran etexilate—CES2—pituitary gland—obesity	0.00117	0.0192	CbGeAlD
Dabigatran etexilate—CES2—adipose tissue—obesity	0.00116	0.0191	CbGeAlD
Dabigatran etexilate—UGT1A9—endocrine gland—obesity	0.00112	0.0184	CbGeAlD
Dabigatran etexilate—UGT2B7—digestive system—obesity	0.0011	0.018	CbGeAlD
Dabigatran etexilate—CES2—digestive system—obesity	0.0011	0.018	CbGeAlD
Dabigatran etexilate—CES1—cardiovascular system—obesity	0.00109	0.0178	CbGeAlD
Dabigatran etexilate—NQO2—pituitary gland—obesity	0.00104	0.0171	CbGeAlD
Dabigatran etexilate—CES2—adrenal gland—obesity	0.00104	0.0171	CbGeAlD
Dabigatran etexilate—NQO2—adipose tissue—obesity	0.00104	0.017	CbGeAlD
Dabigatran etexilate—UGT1A9—liver—obesity	0.00101	0.0166	CbGeAlD
Dabigatran etexilate—F2—digestive system—obesity	0.000983	0.0161	CbGeAlD
Dabigatran etexilate—CES1—adipose tissue—obesity	0.000958	0.0157	CbGeAlD
Dabigatran etexilate—F2—adrenal gland—obesity	0.000936	0.0153	CbGeAlD
Dabigatran etexilate—NQO2—adrenal gland—obesity	0.000933	0.0153	CbGeAlD
Dabigatran etexilate—UGT2B7—endocrine gland—obesity	0.000905	0.0148	CbGeAlD
Dabigatran etexilate—CES2—endocrine gland—obesity	0.000905	0.0148	CbGeAlD
Dabigatran etexilate—CES1—digestive system—obesity	0.000902	0.0148	CbGeAlD
Dabigatran etexilate—CES1—adrenal gland—obesity	0.00086	0.0141	CbGeAlD
Dabigatran etexilate—UGT2B7—liver—obesity	0.000816	0.0134	CbGeAlD
Dabigatran etexilate—CES2—liver—obesity	0.000816	0.0134	CbGeAlD
Dabigatran etexilate—F2—endocrine gland—obesity	0.000812	0.0133	CbGeAlD
Dabigatran etexilate—NQO2—endocrine gland—obesity	0.000809	0.0133	CbGeAlD
Dabigatran etexilate—CES1—endocrine gland—obesity	0.000745	0.0122	CbGeAlD
Dabigatran etexilate—F2—liver—obesity	0.000732	0.012	CbGeAlD
Dabigatran etexilate—NQO2—liver—obesity	0.000729	0.012	CbGeAlD
Dabigatran etexilate—CES1—liver—obesity	0.000672	0.011	CbGeAlD
Dabigatran etexilate—Nasopharyngitis—Bupropion—obesity	0.000354	0.0029	CcSEcCtD
Dabigatran etexilate—ABCB1—islet of Langerhans—obesity	0.000352	0.00577	CbGeAlD
Dabigatran etexilate—Pneumonia—Sibutramine—obesity	0.000352	0.00289	CcSEcCtD
Dabigatran etexilate—Musculoskeletal pain—Topiramate—obesity	0.000351	0.00288	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Orlistat—obesity	0.000351	0.00288	CcSEcCtD
Dabigatran etexilate—Gastritis—Bupropion—obesity	0.00035	0.00287	CcSEcCtD
Dabigatran etexilate—Urticaria—Diethylpropion—obesity	0.000348	0.00286	CcSEcCtD
Dabigatran etexilate—Dizziness—Phenylpropanolamine—obesity	0.000348	0.00286	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Phentermine—obesity	0.000345	0.00283	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Sibutramine—obesity	0.000345	0.00283	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Sibutramine—obesity	0.000343	0.00281	CcSEcCtD
Dabigatran etexilate—Dysphagia—Bupropion—obesity	0.000342	0.0028	CcSEcCtD
Dabigatran etexilate—Influenza—Bupropion—obesity	0.000342	0.0028	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Orlistat—obesity	0.000342	0.0028	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Sibutramine—obesity	0.00034	0.00279	CcSEcCtD
Dabigatran etexilate—Sinusitis—Orlistat—obesity	0.000339	0.00278	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Bupropion—obesity	0.000336	0.00276	CcSEcCtD
Dabigatran etexilate—Vomiting—Phenylpropanolamine—obesity	0.000335	0.00275	CcSEcCtD
Dabigatran etexilate—Dizziness—Phentermine—obesity	0.000333	0.00274	CcSEcCtD
Dabigatran etexilate—Haematuria—Sibutramine—obesity	0.000333	0.00273	CcSEcCtD
Dabigatran etexilate—ABCB1—respiratory system—obesity	0.000332	0.00545	CbGeAlD
Dabigatran etexilate—Rash—Phenylpropanolamine—obesity	0.000332	0.00273	CcSEcCtD
Dabigatran etexilate—Dermatitis—Phenylpropanolamine—obesity	0.000332	0.00272	CcSEcCtD
Dabigatran etexilate—Epistaxis—Sibutramine—obesity	0.00033	0.00271	CcSEcCtD
Dabigatran etexilate—Bronchitis—Bupropion—obesity	0.000329	0.0027	CcSEcCtD
Dabigatran etexilate—Sinusitis—Sibutramine—obesity	0.000328	0.00269	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Bupropion—obesity	0.000328	0.00269	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Orlistat—obesity	0.000326	0.00267	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Orlistat—obesity	0.000324	0.00266	CcSEcCtD
Dabigatran etexilate—Vomiting—Phentermine—obesity	0.00032	0.00263	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Orlistat—obesity	0.00032	0.00263	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Orlistat—obesity	0.000319	0.00262	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Orlistat—obesity	0.000318	0.00261	CcSEcCtD
Dabigatran etexilate—Rash—Phentermine—obesity	0.000318	0.00261	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Bupropion—obesity	0.000318	0.00261	CcSEcCtD
Dabigatran etexilate—Dermatitis—Phentermine—obesity	0.000318	0.00261	CcSEcCtD
Dabigatran etexilate—Oesophagitis—Topiramate—obesity	0.000317	0.0026	CcSEcCtD
Dabigatran etexilate—Headache—Phentermine—obesity	0.000316	0.00259	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Sibutramine—obesity	0.000315	0.00259	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Sibutramine—obesity	0.000314	0.00257	CcSEcCtD
Dabigatran etexilate—Nausea—Phenylpropanolamine—obesity	0.000313	0.00257	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Sibutramine—obesity	0.000309	0.00254	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Cimetidine—obesity	0.000307	0.00252	CcSEcCtD
Dabigatran etexilate—Pneumonia—Bupropion—obesity	0.000306	0.00252	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Bupropion—obesity	0.000305	0.0025	CcSEcCtD
Dabigatran etexilate—Infestation—Bupropion—obesity	0.000305	0.0025	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Bupropion—obesity	0.0003	0.00247	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Diethylpropion—obesity	0.0003	0.00246	CcSEcCtD
Dabigatran etexilate—Nausea—Phentermine—obesity	0.000299	0.00246	CcSEcCtD
Dabigatran etexilate—Asthenia—Cimetidine—obesity	0.000299	0.00246	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Bupropion—obesity	0.000299	0.00245	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Bupropion—obesity	0.000296	0.00243	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Orlistat—obesity	0.000293	0.0024	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Orlistat—obesity	0.000292	0.0024	CcSEcCtD
Dabigatran etexilate—Dizziness—Diethylpropion—obesity	0.00029	0.00238	CcSEcCtD
Dabigatran etexilate—Epistaxis—Bupropion—obesity	0.000287	0.00236	CcSEcCtD
Dabigatran etexilate—Sinusitis—Bupropion—obesity	0.000286	0.00235	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Cimetidine—obesity	0.000285	0.00234	CcSEcCtD
Dabigatran etexilate—Angiopathy—Sibutramine—obesity	0.000285	0.00234	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Sibutramine—obesity	0.000283	0.00233	CcSEcCtD
Dabigatran etexilate—Malnutrition—Orlistat—obesity	0.000282	0.00232	CcSEcCtD
Dabigatran etexilate—ABCB1—adrenal cortex—obesity	0.000279	0.00457	CbGeAlD
Dabigatran etexilate—Vomiting—Diethylpropion—obesity	0.000279	0.00229	CcSEcCtD
Dabigatran etexilate—Flatulence—Orlistat—obesity	0.000278	0.00228	CcSEcCtD
Dabigatran etexilate—Rash—Diethylpropion—obesity	0.000276	0.00227	CcSEcCtD
Dabigatran etexilate—Dermatitis—Diethylpropion—obesity	0.000276	0.00227	CcSEcCtD
Dabigatran etexilate—Dizziness—Cimetidine—obesity	0.000276	0.00226	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Bupropion—obesity	0.000275	0.00226	CcSEcCtD
Dabigatran etexilate—Headache—Diethylpropion—obesity	0.000275	0.00225	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Bupropion—obesity	0.000274	0.00224	CcSEcCtD
Dabigatran etexilate—Malnutrition—Sibutramine—obesity	0.000273	0.00224	CcSEcCtD
Dabigatran etexilate—Back pain—Orlistat—obesity	0.000273	0.00224	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Bupropion—obesity	0.00027	0.00222	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Bupropion—obesity	0.000269	0.00221	CcSEcCtD
Dabigatran etexilate—Flatulence—Sibutramine—obesity	0.000269	0.00221	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Bupropion—obesity	0.000269	0.00221	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Bupropion—obesity	0.000268	0.0022	CcSEcCtD
Dabigatran etexilate—Vomiting—Cimetidine—obesity	0.000265	0.00218	CcSEcCtD
Dabigatran etexilate—Back pain—Sibutramine—obesity	0.000264	0.00217	CcSEcCtD
Dabigatran etexilate—Rash—Cimetidine—obesity	0.000263	0.00216	CcSEcCtD
Dabigatran etexilate—Dermatitis—Cimetidine—obesity	0.000263	0.00216	CcSEcCtD
Dabigatran etexilate—Headache—Cimetidine—obesity	0.000261	0.00214	CcSEcCtD
Dabigatran etexilate—Nausea—Diethylpropion—obesity	0.00026	0.00214	CcSEcCtD
Dabigatran etexilate—Angioedema—Orlistat—obesity	0.000258	0.00212	CcSEcCtD
Dabigatran etexilate—ABCB1—cardiovascular system—obesity	0.000255	0.00417	CbGeAlD
Dabigatran etexilate—Cardiac disorder—Bupropion—obesity	0.000254	0.00208	CcSEcCtD
Dabigatran etexilate—Anaemia—Sibutramine—obesity	0.000252	0.00207	CcSEcCtD
Dabigatran etexilate—Pain in extremity—Topiramate—obesity	0.000252	0.00207	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Topiramate—obesity	0.000252	0.00207	CcSEcCtD
Dabigatran etexilate—Angioedema—Sibutramine—obesity	0.00025	0.00205	CcSEcCtD
Dabigatran etexilate—Palpitations—Orlistat—obesity	0.000249	0.00205	CcSEcCtD
Dabigatran etexilate—Angiopathy—Bupropion—obesity	0.000248	0.00204	CcSEcCtD
Dabigatran etexilate—Nausea—Cimetidine—obesity	0.000248	0.00203	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Bupropion—obesity	0.000247	0.00203	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Bupropion—obesity	0.000247	0.00202	CcSEcCtD
Dabigatran etexilate—Cough—Orlistat—obesity	0.000246	0.00202	CcSEcCtD
Dabigatran etexilate—Syncope—Sibutramine—obesity	0.000245	0.00201	CcSEcCtD
Dabigatran etexilate—Palpitations—Sibutramine—obesity	0.000241	0.00198	CcSEcCtD
Dabigatran etexilate—Chest pain—Orlistat—obesity	0.00024	0.00197	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Sibutramine—obesity	0.00024	0.00197	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000239	0.00196	CcSEcCtD
Dabigatran etexilate—Cough—Sibutramine—obesity	0.000238	0.00196	CcSEcCtD
Dabigatran etexilate—Malnutrition—Bupropion—obesity	0.000238	0.00195	CcSEcCtD
Dabigatran etexilate—Hypertension—Sibutramine—obesity	0.000236	0.00194	CcSEcCtD
Dabigatran etexilate—Flatulence—Bupropion—obesity	0.000235	0.00193	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Topiramate—obesity	0.000233	0.00191	CcSEcCtD
Dabigatran etexilate—Arthralgia—Sibutramine—obesity	0.000233	0.00191	CcSEcCtD
Dabigatran etexilate—Chest pain—Sibutramine—obesity	0.000233	0.00191	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Orlistat—obesity	0.00023	0.00189	CcSEcCtD
Dabigatran etexilate—Back pain—Bupropion—obesity	0.00023	0.00189	CcSEcCtD
Dabigatran etexilate—Abdominal pain upper—Topiramate—obesity	0.00023	0.00189	CcSEcCtD
Dabigatran etexilate—Infection—Orlistat—obesity	0.000229	0.00188	CcSEcCtD
Dabigatran etexilate—Aspartate aminotransferase increased—Topiramate—obesity	0.000227	0.00186	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Orlistat—obesity	0.000226	0.00185	CcSEcCtD
Dabigatran etexilate—ABCB1—pituitary gland—obesity	0.000225	0.00369	CbGeAlD
Dabigatran etexilate—Nasopharyngitis—Topiramate—obesity	0.000225	0.00185	CcSEcCtD
Dabigatran etexilate—ABCB1—adipose tissue—obesity	0.000224	0.00368	CbGeAlD
Dabigatran etexilate—Skin disorder—Orlistat—obesity	0.000224	0.00184	CcSEcCtD
Dabigatran etexilate—Gastritis—Topiramate—obesity	0.000223	0.00183	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Sibutramine—obesity	0.000223	0.00183	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Topiramate—obesity	0.000222	0.00182	CcSEcCtD
Dabigatran etexilate—Infection—Sibutramine—obesity	0.000221	0.00182	CcSEcCtD
Dabigatran etexilate—Anaemia—Bupropion—obesity	0.00022	0.00181	CcSEcCtD
Dabigatran etexilate—Shock—Sibutramine—obesity	0.000219	0.0018	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Sibutramine—obesity	0.000218	0.00179	CcSEcCtD
Dabigatran etexilate—Dysphagia—Topiramate—obesity	0.000218	0.00179	CcSEcCtD
Dabigatran etexilate—Angioedema—Bupropion—obesity	0.000218	0.00179	CcSEcCtD
Dabigatran etexilate—Skin disorder—Sibutramine—obesity	0.000217	0.00178	CcSEcCtD
Dabigatran etexilate—Syncope—Bupropion—obesity	0.000214	0.00175	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Topiramate—obesity	0.000212	0.00174	CcSEcCtD
Dabigatran etexilate—ABCB1—digestive system—obesity	0.000211	0.00346	CbGeAlD
Dabigatran etexilate—Palpitations—Bupropion—obesity	0.00021	0.00173	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Orlistat—obesity	0.00021	0.00172	CcSEcCtD
Dabigatran etexilate—Bronchitis—Topiramate—obesity	0.000209	0.00172	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Bupropion—obesity	0.000209	0.00172	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Topiramate—obesity	0.000209	0.00171	CcSEcCtD
Dabigatran etexilate—Hypotension—Sibutramine—obesity	0.000208	0.00171	CcSEcCtD
Dabigatran etexilate—Cough—Bupropion—obesity	0.000208	0.00171	CcSEcCtD
Dabigatran etexilate—Hypertension—Bupropion—obesity	0.000206	0.00169	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Sibutramine—obesity	0.000203	0.00167	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Orlistat—obesity	0.000203	0.00166	CcSEcCtD
Dabigatran etexilate—Arthralgia—Bupropion—obesity	0.000203	0.00166	CcSEcCtD
Dabigatran etexilate—Chest pain—Bupropion—obesity	0.000203	0.00166	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Topiramate—obesity	0.000202	0.00166	CcSEcCtD
Dabigatran etexilate—ABCB1—adrenal gland—obesity	0.000201	0.0033	CbGeAlD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000201	0.00165	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Orlistat—obesity	0.000199	0.00163	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Sibutramine—obesity	0.000199	0.00163	CcSEcCtD
Dabigatran etexilate—Fatigue—Orlistat—obesity	0.000199	0.00163	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Sibutramine—obesity	0.000196	0.00161	CcSEcCtD
Dabigatran etexilate—Pneumonia—Topiramate—obesity	0.000195	0.0016	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Bupropion—obesity	0.000194	0.00159	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Topiramate—obesity	0.000194	0.00159	CcSEcCtD
Dabigatran etexilate—Infestation—Topiramate—obesity	0.000194	0.00159	CcSEcCtD
Dabigatran etexilate—Infection—Bupropion—obesity	0.000193	0.00158	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Sibutramine—obesity	0.000192	0.00158	CcSEcCtD
Dabigatran etexilate—Shock—Bupropion—obesity	0.000191	0.00157	CcSEcCtD
Dabigatran etexilate—Constipation—Sibutramine—obesity	0.000191	0.00156	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Bupropion—obesity	0.000191	0.00156	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Bupropion—obesity	0.00019	0.00156	CcSEcCtD
Dabigatran etexilate—Skin disorder—Bupropion—obesity	0.000189	0.00155	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Topiramate—obesity	0.000189	0.00155	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Orlistat—obesity	0.000188	0.00155	CcSEcCtD
Dabigatran etexilate—Haematuria—Topiramate—obesity	0.000185	0.00152	CcSEcCtD
Dabigatran etexilate—Epistaxis—Topiramate—obesity	0.000183	0.0015	CcSEcCtD
Dabigatran etexilate—Urticaria—Orlistat—obesity	0.000183	0.0015	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Sibutramine—obesity	0.000182	0.0015	CcSEcCtD
Dabigatran etexilate—Sinusitis—Topiramate—obesity	0.000182	0.00149	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Orlistat—obesity	0.000182	0.00149	CcSEcCtD
Dabigatran etexilate—Hypotension—Bupropion—obesity	0.000182	0.00149	CcSEcCtD
Dabigatran etexilate—Urticaria—Sibutramine—obesity	0.000177	0.00145	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Bupropion—obesity	0.000177	0.00145	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Sibutramine—obesity	0.000176	0.00145	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Topiramate—obesity	0.000175	0.00144	CcSEcCtD
Dabigatran etexilate—ABCB1—endocrine gland—obesity	0.000175	0.00286	CbGeAlD
Dabigatran etexilate—Haemorrhage—Topiramate—obesity	0.000174	0.00143	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Bupropion—obesity	0.000173	0.00142	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Topiramate—obesity	0.000172	0.00141	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Topiramate—obesity	0.000172	0.00141	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Topiramate—obesity	0.000171	0.00141	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Bupropion—obesity	0.000171	0.0014	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Topiramate—obesity	0.000171	0.0014	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Orlistat—obesity	0.00017	0.00139	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Bupropion—obesity	0.000168	0.00138	CcSEcCtD
Dabigatran etexilate—Fatigue—Bupropion—obesity	0.000168	0.00137	CcSEcCtD
Dabigatran etexilate—Constipation—Bupropion—obesity	0.000166	0.00136	CcSEcCtD
Dabigatran etexilate—Asthenia—Orlistat—obesity	0.000165	0.00136	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Sibutramine—obesity	0.000164	0.00135	CcSEcCtD
Dabigatran etexilate—Pruritus—Orlistat—obesity	0.000163	0.00134	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Topiramate—obesity	0.000162	0.00133	CcSEcCtD
Dabigatran etexilate—Asthenia—Sibutramine—obesity	0.00016	0.00131	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Bupropion—obesity	0.000159	0.0013	CcSEcCtD
Dabigatran etexilate—Angiopathy—Topiramate—obesity	0.000158	0.0013	CcSEcCtD
Dabigatran etexilate—Pruritus—Sibutramine—obesity	0.000158	0.00129	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Orlistat—obesity	0.000158	0.00129	CcSEcCtD
Dabigatran etexilate—ABCB1—liver—obesity	0.000157	0.00258	CbGeAlD
Dabigatran etexilate—Immune system disorder—Topiramate—obesity	0.000157	0.00129	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Topiramate—obesity	0.000157	0.00129	CcSEcCtD
Dabigatran etexilate—Urticaria—Bupropion—obesity	0.000154	0.00127	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Bupropion—obesity	0.000154	0.00126	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Sibutramine—obesity	0.000153	0.00125	CcSEcCtD
Dabigatran etexilate—Dizziness—Orlistat—obesity	0.000152	0.00125	CcSEcCtD
Dabigatran etexilate—Malnutrition—Topiramate—obesity	0.000152	0.00124	CcSEcCtD
Dabigatran etexilate—Flatulence—Topiramate—obesity	0.000149	0.00123	CcSEcCtD
Dabigatran etexilate—Dizziness—Sibutramine—obesity	0.000147	0.00121	CcSEcCtD
Dabigatran etexilate—Back pain—Topiramate—obesity	0.000147	0.0012	CcSEcCtD
Dabigatran etexilate—Vomiting—Orlistat—obesity	0.000146	0.0012	CcSEcCtD
Dabigatran etexilate—Rash—Orlistat—obesity	0.000145	0.00119	CcSEcCtD
Dabigatran etexilate—Dermatitis—Orlistat—obesity	0.000145	0.00119	CcSEcCtD
Dabigatran etexilate—Headache—Orlistat—obesity	0.000144	0.00118	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Bupropion—obesity	0.000143	0.00117	CcSEcCtD
Dabigatran etexilate—Vomiting—Sibutramine—obesity	0.000142	0.00116	CcSEcCtD
Dabigatran etexilate—Rash—Sibutramine—obesity	0.000141	0.00115	CcSEcCtD
Dabigatran etexilate—Dermatitis—Sibutramine—obesity	0.00014	0.00115	CcSEcCtD
Dabigatran etexilate—Anaemia—Topiramate—obesity	0.00014	0.00115	CcSEcCtD
Dabigatran etexilate—Headache—Sibutramine—obesity	0.00014	0.00115	CcSEcCtD
Dabigatran etexilate—Asthenia—Bupropion—obesity	0.000139	0.00114	CcSEcCtD
Dabigatran etexilate—Pruritus—Bupropion—obesity	0.000137	0.00113	CcSEcCtD
Dabigatran etexilate—Nausea—Orlistat—obesity	0.000137	0.00112	CcSEcCtD
Dabigatran etexilate—Syncope—Topiramate—obesity	0.000136	0.00112	CcSEcCtD
Dabigatran etexilate—Palpitations—Topiramate—obesity	0.000134	0.0011	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Topiramate—obesity	0.000133	0.00109	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Bupropion—obesity	0.000133	0.00109	CcSEcCtD
Dabigatran etexilate—Nausea—Sibutramine—obesity	0.000132	0.00109	CcSEcCtD
Dabigatran etexilate—Cough—Topiramate—obesity	0.000132	0.00109	CcSEcCtD
Dabigatran etexilate—Hypertension—Topiramate—obesity	0.000131	0.00107	CcSEcCtD
Dabigatran etexilate—Chest pain—Topiramate—obesity	0.000129	0.00106	CcSEcCtD
Dabigatran etexilate—Arthralgia—Topiramate—obesity	0.000129	0.00106	CcSEcCtD
Dabigatran etexilate—Dizziness—Bupropion—obesity	0.000129	0.00105	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000128	0.00105	CcSEcCtD
Dabigatran etexilate—Vomiting—Bupropion—obesity	0.000124	0.00101	CcSEcCtD
Dabigatran etexilate—Infection—Topiramate—obesity	0.000123	0.00101	CcSEcCtD
Dabigatran etexilate—Rash—Bupropion—obesity	0.000123	0.00101	CcSEcCtD
Dabigatran etexilate—Dermatitis—Bupropion—obesity	0.000122	0.001	CcSEcCtD
Dabigatran etexilate—Shock—Topiramate—obesity	0.000122	0.001	CcSEcCtD
Dabigatran etexilate—Headache—Bupropion—obesity	0.000122	0.000999	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Topiramate—obesity	0.000121	0.000996	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Topiramate—obesity	0.000121	0.000995	CcSEcCtD
Dabigatran etexilate—Skin disorder—Topiramate—obesity	0.00012	0.000987	CcSEcCtD
Dabigatran etexilate—Hypotension—Topiramate—obesity	0.000116	0.000949	CcSEcCtD
Dabigatran etexilate—Nausea—Bupropion—obesity	0.000115	0.000947	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Topiramate—obesity	0.000113	0.000926	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Topiramate—obesity	0.00011	0.000906	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Topiramate—obesity	0.000109	0.000894	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Topiramate—obesity	0.000107	0.000877	CcSEcCtD
Dabigatran etexilate—Fatigue—Topiramate—obesity	0.000107	0.000876	CcSEcCtD
Dabigatran etexilate—Constipation—Topiramate—obesity	0.000106	0.000869	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Topiramate—obesity	0.000101	0.000831	CcSEcCtD
Dabigatran etexilate—Urticaria—Topiramate—obesity	9.84e-05	0.000807	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Topiramate—obesity	9.79e-05	0.000803	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Topiramate—obesity	9.12e-05	0.000749	CcSEcCtD
Dabigatran etexilate—Asthenia—Topiramate—obesity	8.88e-05	0.000729	CcSEcCtD
Dabigatran etexilate—Pruritus—Topiramate—obesity	8.76e-05	0.000719	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Topiramate—obesity	8.47e-05	0.000695	CcSEcCtD
Dabigatran etexilate—Dizziness—Topiramate—obesity	8.19e-05	0.000672	CcSEcCtD
Dabigatran etexilate—Vomiting—Topiramate—obesity	7.87e-05	0.000646	CcSEcCtD
Dabigatran etexilate—Rash—Topiramate—obesity	7.81e-05	0.000641	CcSEcCtD
Dabigatran etexilate—Dermatitis—Topiramate—obesity	7.8e-05	0.00064	CcSEcCtD
Dabigatran etexilate—Headache—Topiramate—obesity	7.76e-05	0.000637	CcSEcCtD
Dabigatran etexilate—Nausea—Topiramate—obesity	7.35e-05	0.000604	CcSEcCtD
Dabigatran etexilate—ABCB1—Metabolism—SAT1—obesity	8.89e-06	6.16e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PFKFB3—obesity	8.89e-06	6.16e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ANGPTL4—obesity	8.89e-06	6.16e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ACADM—obesity	8.89e-06	6.16e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PLIN1—obesity	8.89e-06	6.16e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PNPLA2—obesity	8.89e-06	6.16e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—COMT—obesity	8.83e-06	6.12e-05	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PIK3CD—obesity	8.81e-06	6.11e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GNB3—obesity	8.7e-06	6.03e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARGC1A—obesity	8.7e-06	6.03e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TGFB1—obesity	8.7e-06	6.03e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HMOX1—obesity	8.66e-06	6.01e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—POMC—obesity	8.66e-06	6e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP2E1—obesity	8.66e-06	6e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—OXCT1—obesity	8.65e-06	6e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ACACB—obesity	8.65e-06	6e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYTB—obesity	8.65e-06	6e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PRL—obesity	8.64e-06	5.99e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NQO1—obesity	8.56e-06	5.93e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—STK11—obesity	8.51e-06	5.9e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GNAS—obesity	8.48e-06	5.87e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL2—obesity	8.47e-06	5.87e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PNLIP—obesity	8.43e-06	5.84e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SRD5A1—obesity	8.43e-06	5.84e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PLG—obesity	8.42e-06	5.84e-05	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—RHOA—obesity	8.4e-06	5.83e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	8.38e-06	5.81e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AKT2—obesity	8.33e-06	5.77e-05	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PIK3R1—obesity	8.32e-06	5.77e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—obesity	8.31e-06	5.76e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOB—obesity	8.3e-06	5.75e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SDC3—obesity	8.23e-06	5.7e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FOXO3—obesity	8.22e-06	5.7e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SLC2A4—obesity	8.21e-06	5.69e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GCG—obesity	8.21e-06	5.69e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADRB2—obesity	8.19e-06	5.68e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYCS—obesity	8.1e-06	5.61e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SOCS1—obesity	8.07e-06	5.59e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP26B1—obesity	8.04e-06	5.57e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—STS—obesity	8.04e-06	5.57e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HK2—obesity	8.04e-06	5.57e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC2A4—obesity	8.04e-06	5.57e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PIK3CD—obesity	8e-06	5.54e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SOCS3—obesity	7.97e-06	5.53e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GOT1—obesity	7.95e-06	5.51e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GGT1—obesity	7.95e-06	5.51e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—CYCS—obesity	7.93e-06	5.5e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—LPL—obesity	7.93e-06	5.49e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARD—obesity	7.87e-06	5.45e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NCOA1—obesity	7.83e-06	5.43e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GNB3—obesity	7.8e-06	5.41e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	7.78e-06	5.4e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GPX1—obesity	7.73e-06	5.36e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—STK11—obesity	7.72e-06	5.35e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP19A1—obesity	7.72e-06	5.35e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC27A1—obesity	7.71e-06	5.34e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—TYK2—obesity	7.7e-06	5.33e-05	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PIK3CB—obesity	7.68e-06	5.32e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—NCOA1—obesity	7.67e-06	5.32e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IGF2—obesity	7.67e-06	5.31e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—RHOA—obesity	7.63e-06	5.29e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GNAS—obesity	7.6e-06	5.27e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GLUL—obesity	7.56e-06	5.24e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—FABP4—obesity	7.56e-06	5.24e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PIK3R1—obesity	7.55e-06	5.24e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CD36—obesity	7.53e-06	5.22e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—PLG—obesity	7.47e-06	5.18e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOB—obesity	7.44e-06	5.16e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PIK3CA—obesity	7.41e-06	5.13e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL5—obesity	7.27e-06	5.04e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—COMT—obesity	7.17e-06	4.97e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ECHS1—obesity	7.17e-06	4.97e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—UCP3—obesity	7.17e-06	4.97e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—UCP2—obesity	7.17e-06	4.97e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HSD11B1—obesity	7.17e-06	4.97e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—MTHFR—obesity	7.14e-06	4.95e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LPL—obesity	7.11e-06	4.93e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GNB3—obesity	7.07e-06	4.9e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARGC1A—obesity	7.07e-06	4.9e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FOXO1—obesity	7.05e-06	4.89e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADH1B—obesity	7.05e-06	4.89e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RPS6KB1—obesity	7.04e-06	4.88e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HMOX1—obesity	7.04e-06	4.88e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARA—obesity	7e-06	4.85e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PIK3CB—obesity	6.97e-06	4.83e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ACSL1—obesity	6.94e-06	4.81e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GPAM—obesity	6.94e-06	4.81e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARGC1B—obesity	6.94e-06	4.81e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—GNB3—obesity	6.93e-06	4.8e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—HMOX1—obesity	6.9e-06	4.78e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GNAS—obesity	6.89e-06	4.77e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AGT—obesity	6.78e-06	4.7e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—GNAS—obesity	6.75e-06	4.68e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOB—obesity	6.74e-06	4.68e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PCK1—obesity	6.74e-06	4.67e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HADH—obesity	6.74e-06	4.67e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—FADS1—obesity	6.74e-06	4.67e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOE—obesity	6.64e-06	4.6e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—obesity	6.61e-06	4.58e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—APOB—obesity	6.61e-06	4.58e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	6.6e-06	4.57e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CAV1—obesity	6.58e-06	4.56e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOA1—obesity	6.57e-06	4.55e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ACP5—obesity	6.55e-06	4.54e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PRKCD—obesity	6.55e-06	4.54e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—LPL—obesity	6.44e-06	4.46e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR2A—obesity	6.41e-06	4.44e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—C3—obesity	6.4e-06	4.43e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—G6PD—obesity	6.39e-06	4.43e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HK1—obesity	6.31e-06	4.37e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SREBF2—obesity	6.31e-06	4.37e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GPX1—obesity	6.28e-06	4.36e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—obesity	6.16e-06	4.27e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PIK3CA—obesity	6.15e-06	4.26e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CD36—obesity	6.12e-06	4.24e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LPA—obesity	6.09e-06	4.22e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IRS2—obesity	6.09e-06	4.22e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AGT—obesity	6.08e-06	4.21e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—AKT1—obesity	6.05e-06	4.19e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PIK3CG—obesity	6e-06	4.16e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LPIN1—obesity	5.96e-06	4.13e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LEP—obesity	5.96e-06	4.13e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOE—obesity	5.96e-06	4.13e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CAV1—obesity	5.9e-06	4.09e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOA1—obesity	5.89e-06	4.08e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOA5—obesity	5.84e-06	4.05e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—MTHFR—obesity	5.8e-06	4.02e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARG—obesity	5.79e-06	4.01e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—POMC—obesity	5.71e-06	3.96e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARA—obesity	5.69e-06	3.94e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ESR1—obesity	5.69e-06	3.94e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—INS—obesity	5.68e-06	3.93e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PRKCB—obesity	5.62e-06	3.89e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	5.61e-06	3.89e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CLOCK—obesity	5.57e-06	3.86e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC22A1—obesity	5.57e-06	3.86e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—PPARA—obesity	5.57e-06	3.86e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—BAD—obesity	5.55e-06	3.85e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AGT—obesity	5.51e-06	3.82e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SULT2A1—obesity	5.43e-06	3.76e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GLP1R—obesity	5.43e-06	3.76e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOE—obesity	5.4e-06	3.74e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PIK3CG—obesity	5.38e-06	3.73e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CAV1—obesity	5.35e-06	3.71e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—DPYD—obesity	5.34e-06	3.7e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOA1—obesity	5.34e-06	3.7e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IRS1—obesity	5.31e-06	3.68e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PIK3CD—obesity	5.27e-06	3.65e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—APOA1—obesity	5.23e-06	3.62e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALB—obesity	5.2e-06	3.61e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PRKAR2B—obesity	5.14e-06	3.57e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—POMC—obesity	5.12e-06	3.55e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	5.11e-06	3.54e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—DCN—obesity	5.11e-06	3.54e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—INS—obesity	5.09e-06	3.53e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AKT1—obesity	5.02e-06	3.48e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL2—obesity	5.01e-06	3.47e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PIK3R1—obesity	4.98e-06	3.45e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NOS3—obesity	4.98e-06	3.45e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CPT1A—obesity	4.97e-06	3.44e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IGF1—obesity	4.92e-06	3.41e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKT2—obesity	4.92e-06	3.41e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NAMPT—obesity	4.87e-06	3.38e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PIK3CG—obesity	4.87e-06	3.38e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LIPC—obesity	4.84e-06	3.36e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GCK—obesity	4.84e-06	3.36e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOC3—obesity	4.81e-06	3.33e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PIK3CD—obesity	4.73e-06	3.28e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARG—obesity	4.7e-06	3.26e-05	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PIK3CA—obesity	4.68e-06	3.24e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SERPINE1—obesity	4.67e-06	3.24e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CETP—obesity	4.67e-06	3.24e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—POMC—obesity	4.64e-06	3.21e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SDC1—obesity	4.62e-06	3.2e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—INS—obesity	4.61e-06	3.2e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PIK3CB—obesity	4.59e-06	3.18e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	4.59e-06	3.18e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS2—obesity	4.55e-06	3.16e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TYK2—obesity	4.55e-06	3.15e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AKR1C3—obesity	4.54e-06	3.15e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RHOA—obesity	4.51e-06	3.13e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SCARB1—obesity	4.47e-06	3.1e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PIK3R1—obesity	4.46e-06	3.09e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NOS3—obesity	4.46e-06	3.09e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SREBF1—obesity	4.34e-06	3.01e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PIK3CD—obesity	4.28e-06	2.97e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PIK3CA—obesity	4.25e-06	2.95e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALB—obesity	4.23e-06	2.93e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GOT2—obesity	4.22e-06	2.93e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ALB—obesity	4.14e-06	2.87e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—FASN—obesity	4.13e-06	2.87e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PIK3CB—obesity	4.12e-06	2.85e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MTOR—obesity	4.12e-06	2.85e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—BCHE—obesity	4.12e-06	2.85e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PIK3R1—obesity	4.04e-06	2.8e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NOS3—obesity	4.04e-06	2.8e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP2E1—obesity	3.97e-06	2.75e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NQO1—obesity	3.93e-06	2.72e-05	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AKT1—obesity	3.82e-06	2.65e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC2A4—obesity	3.76e-06	2.61e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GCG—obesity	3.76e-06	2.61e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6—obesity	3.76e-06	2.61e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PIK3CB—obesity	3.73e-06	2.59e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYCS—obesity	3.72e-06	2.58e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS2—obesity	3.7e-06	2.56e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GGT1—obesity	3.65e-06	2.53e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GOT1—obesity	3.65e-06	2.53e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NCOA1—obesity	3.59e-06	2.49e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP9—obesity	3.58e-06	2.48e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—STK11—obesity	3.54e-06	2.45e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP19A1—obesity	3.54e-06	2.45e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MAPK8—obesity	3.48e-06	2.41e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AKT1—obesity	3.47e-06	2.41e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—COMT—obesity	3.29e-06	2.28e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GNB3—obesity	3.24e-06	2.25e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARGC1A—obesity	3.24e-06	2.25e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HMOX1—obesity	3.23e-06	2.24e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—STAT3—obesity	3.18e-06	2.21e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GNAS—obesity	3.16e-06	2.19e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOB—obesity	3.09e-06	2.14e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MYC—obesity	2.96e-06	2.05e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LPL—obesity	2.95e-06	2.05e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TGFB1—obesity	2.95e-06	2.05e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GPX1—obesity	2.88e-06	2e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CD36—obesity	2.81e-06	1.95e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PIK3CA—obesity	2.8e-06	1.94e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—MTHFR—obesity	2.66e-06	1.84e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARA—obesity	2.61e-06	1.81e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AGT—obesity	2.53e-06	1.75e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PIK3CA—obesity	2.51e-06	1.74e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOE—obesity	2.48e-06	1.72e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CAV1—obesity	2.45e-06	1.7e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOA1—obesity	2.45e-06	1.7e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AKT1—obesity	2.29e-06	1.59e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PIK3CA—obesity	2.28e-06	1.58e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PIK3CG—obesity	2.23e-06	1.55e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6—obesity	2.22e-06	1.54e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARG—obesity	2.16e-06	1.5e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—POMC—obesity	2.13e-06	1.47e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—INS—obesity	2.12e-06	1.47e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKT1—obesity	2.05e-06	1.42e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PIK3CD—obesity	1.96e-06	1.36e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALB—obesity	1.94e-06	1.34e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AKT1—obesity	1.86e-06	1.29e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NOS3—obesity	1.86e-06	1.29e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PIK3R1—obesity	1.86e-06	1.29e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PIK3CB—obesity	1.71e-06	1.19e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS2—obesity	1.7e-06	1.18e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PIK3CA—obesity	1.04e-06	7.24e-06	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AKT1—obesity	8.53e-07	5.91e-06	CbGpPWpGaD
